Our Global Impact
We stretch across borders to break barriers in women’s health around the world.
Global Strategy
Medicines360’s mission is global in scope. We are dedicated to improving the health of women not just in the United States but around the world. We partner with global health organizations, nonprofits, and governments to ensure that our innovations reach women in even the most remote and underserved regions.
Addressing Global Health Disparities
An estimated 218 million women living in low- and middle-income countries have an unmet need for modern contraception. Each year, this unmet need results in 111 million unintended pregnancies (nearly half of all pregnancies), contributing to 35 million abortions, 2.5 million newborn deaths, and 300,000 maternal deaths. Adoption of modern contraception could reduce unintended pregnancy by 68%, unsafe abortions by 72%, newborn deaths by 69%, and maternal deaths by 62%*.
218M
Women have unmet needs for modern contraception.
111M
Unintended pregnancies result from inadequate contraception, annually.
300K
Maternal deaths result from inadequate contraception, annually.
Our Hormonal IUD Global Access Strategy
Medicines360 is rapidly expanding access to Avibela™, our hormonal IUD, to women living in Africa, South and Southeast Asia, Central America and the Caribbean.
AVIBELA, our hormonal IUD, can be made available in the 88 countries highlighted on this map.
Our strategy is built on three pillars:
DKT WomanCare Partnership
We need partners to scale our impact. Our partnership with DKT WomanCare Global allows us to distribute AVIBELA in dozens of countries and raise awareness about our product.
Alternative Manufacturing
We are committed to making AVIBELA a viable contraceptive option in all markets. To sustain the affordable price of our product, we’re moving our manufacturing from Europe to India.
Philanthropic Resources
Philanthropy fuels our mission. We operate our Global program with grants and donations from private foundations and individuals.
Our Commitment
In 2015, Medicines360 made the hormonal IUD available at the lowest price ever. Our affordable price galvanized a global coalition committed to expanding access to this largely unavailable product. To grow our global footprint, we have registered AVIBELA in 11 countries in Africa, with five more pending approval and many more in the pipeline.
Our Impact
Since 2019, Medicines360 has supplied >43,000 units of AVIBELA, representing >208,000 Couple-Years of Protection (CYPs), averting an estimated 65,700 unplanned pregnancies, 21,200 unsafe abortions, 100 maternal deaths, and 900 child deaths, and saving an estimated $3.7 million in direct healthcare costs.
Meet Honorina
Honorina is a Malagasy woman studying to become a seamstress. Honorina wanted to protect herself from getting pregnant until she was ready. Honorina stopped using injectables because it was too tough to make it to the clinic every three months. A family planning educator told her about the range of methods and described how AVIBELA could address her heavy periods, which attracted Honorina to the method. Honorina was able to continue her studies without the stress of getting pregnant.
